Amgen
The Precision Medicine Global Biomarker Lead drives biomarker research and clinical strategies within oncology studies to support the translation and development of Amgen's products. This role involves developing testable hypotheses for patient stratification, pharmacodynamics, and resistance evidence to inform critical decision-making. The position requires collaboration with cross-functional teams, external partners, and key opinion leaders to integrate aligned biomarker evidence plans. The role also includes interpreting and communicating key clinical biomarker findings to leadership and scientific peers.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Precision Medicine Global Biomarker Lead, Rare Disease
lifelancer
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Biomarker Strategy Lead
Denali Therapeutics
Principal Scientist, Precision Medicine (Biomarker) Strategy Lead
Regeneron Pharmaceuticals
Associate Director, Clinical Biomarker
lifelancer
China Biomarker Lead
Takeda Pharmaceuticals Korea Co., Ltd.